These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1581 related items for PubMed ID: 9169644

  • 1. Association of donor-derived host-reactive cytolytic and helper T cells with outcome following alternative donor T cell-depleted bone marrow transplantation.
    Keever-Taylor CA, Passweg J, Kawanishi Y, Casper J, Flomenberg N, Baxter-Lowe LA.
    Bone Marrow Transplant; 1997 May; 19(10):1001-9. PubMed ID: 9169644
    [Abstract] [Full Text] [Related]

  • 2. Alloreactivity and the predictive value of anti-recipient specific interleukin 2 producing helper T lymphocyte precursor frequencies for alloreactivity after bone marrow transplantation.
    Russell CA.
    Dan Med Bull; 2002 May; 49(2):89-108. PubMed ID: 12064093
    [Abstract] [Full Text] [Related]

  • 3. [Frequency of cytotoxic and helper T-lymphocyte precursors in donors with alloreactivity to recipient histocompatibility antigens. Possible use in predicting acute graft vs host disease in bone marrow transplantation].
    Cukrová V, Dolezalová L, Loudová M, Vítek A, Starý J.
    Cas Lek Cesk; 1997 Feb 05; 136(3):80-4. PubMed ID: 9221174
    [Abstract] [Full Text] [Related]

  • 4. Helper and cytotoxic T cell precursor frequencies are not predictive for development of acute graft-versus-host disease after partially T cell-depleted HLA-identical sibling BMT.
    van der Meer A, Allebes WA, Voorter CE, van den Berg-Loonen EM, Schattenberg AV, de Witte TJ, Joosten I.
    Bone Marrow Transplant; 1998 Dec 05; 22(11):1049-55. PubMed ID: 9877266
    [Abstract] [Full Text] [Related]

  • 5. Analysis of risk factors for the development of GVHD after T cell-depleted allogeneic BMT: effect of HLA disparity, ABO incompatibility, and method of T-cell depletion.
    Keever-Taylor CA, Bredeson C, Loberiza FR, Casper JT, Lawton C, Rizzo D, Burns WH, Margolis DA, Vesole DH, Horowitz M, Zhang MJ, Juckett M, Drobyski WR.
    Biol Blood Marrow Transplant; 2001 Dec 05; 7(11):620-30. PubMed ID: 11760150
    [Abstract] [Full Text] [Related]

  • 6. CD6+ T cell depleted allogeneic bone marrow transplantation from genotypically HLA nonidentical related donors.
    Soiffer RJ, Mauch P, Fairclough D, Alyea E, Anderson K, Fisher D, Freedman A, Bartlett-Pandite L, Robertson M, Schlossman R, Gollob J, Marcus K, Murray C, Kuhlman C, Freeman A, Nadler L, Ritz J.
    Biol Blood Marrow Transplant; 1997 Apr 05; 3(1):11-7. PubMed ID: 9209736
    [Abstract] [Full Text] [Related]

  • 7. Helper T-lymphocyte precursor frequency predicts the occurrence of graft-versus-host disease and disease relapse after allogeneic bone marrow transplantation from HLA-identical siblings.
    Leung AY, Kwok J, Lie AK, Chen P, Chen FE, Liang R.
    Haematologica; 2001 Jun 05; 86(6):652-6. PubMed ID: 11418376
    [Abstract] [Full Text] [Related]

  • 8. Comparison of helper and cytotoxic antirecipient T cell frequencies in unrelated bone marrow transplantation.
    Schwarer AP, Jiang YZ, Deacock S, Brookes PA, Barrett AJ, Goldman JM, Batchelor JR, Lechler RI.
    Transplantation; 1994 Dec 15; 58(11):1198-203. PubMed ID: 7992363
    [Abstract] [Full Text] [Related]

  • 9. T-cell frequency analysis does not predict the incidence of graft-versus-host disease in HLA-matched sibling bone marrow transplantation.
    Wang XN, Taylor PR, Skinner R, Jackson GH, Proctor SJ, Hedley D, Dickinson AM.
    Transplantation; 2000 Aug 15; 70(3):488-93. PubMed ID: 10949192
    [Abstract] [Full Text] [Related]

  • 10. The predictive value of helper T lymphocyte precursor frequencies for graft-versus-host disease and graft-versus-leukaemia effects in allogeneic bone marrow transplantation.
    Russell CA, Heilmann C, Madsen HO, Vindeløv LL.
    Bone Marrow Transplant; 2001 May 15; 27(9):949-58. PubMed ID: 11436105
    [Abstract] [Full Text] [Related]

  • 11. Cytotoxic T lymphocyte precursor frequency analyses in bone marrow transplantation with volunteer unrelated donors. Value in donor selection.
    Spencer A, Brookes PA, Kaminski E, Hows JM, Szydlo RM, van Rhee F, Goldman JM, Batchelor JR.
    Transplantation; 1995 May 15; 59(9):1302-8. PubMed ID: 7762066
    [Abstract] [Full Text] [Related]

  • 12. T-cell precursor frequencies and long-term outcome following unrelated hematopoietic stem cell transplantation.
    Kircher B, Niederwieser D, Gächter A, Lindner B, Mitterschiffthaler A, Urban C, Greinix H, Peters C, Lätzer K, Gastl G, Nachbaur D.
    Int J Lab Hematol; 2008 Dec 15; 30(6):499-507. PubMed ID: 18522713
    [Abstract] [Full Text] [Related]

  • 13. Frequency analysis of cytotoxic T lymphocyte precursors in search for donors in bone marrow transplantation.
    Cukrová V, Dolezalová L, Loudová M, Matĕjková E, Korínková P, Lukásová M, Starý J.
    Neoplasma; 1995 Dec 15; 42(1):3-8. PubMed ID: 7617071
    [Abstract] [Full Text] [Related]

  • 14. Graft-versus-leukaemia following allogeneic bone marrow transplantation: emergence of cytotoxic T lymphocytes reacting to host leukaemia cells.
    Jiang YZ, Kanfer EJ, Macdonald D, Cullis JO, Goldman JM, Barrett AJ.
    Bone Marrow Transplant; 1991 Oct 15; 8(4):253-8. PubMed ID: 1756322
    [Abstract] [Full Text] [Related]

  • 15. The helper T lymphocyte precursor (HTLp) frequency does not predict outcome after HLA-identical sibling donor G-CSF-mobilised peripheral blood stem cell transplantation.
    Healey G, Schwarer AP.
    Bone Marrow Transplant; 2002 Sep 15; 30(6):341-6. PubMed ID: 12235517
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. No predictive value of cytotoxic or helper T-cell precursor frequencies for outcome when analyzed from the graft after stem cell transplantation.
    Kircher B, Niederwieser D, Gächter A, Lätzer K, Eibl G, Gastl G, Nachbaur D.
    Ann Hematol; 2004 Sep 15; 83(9):566-72. PubMed ID: 15170521
    [Abstract] [Full Text] [Related]

  • 18. European results of matched unrelated donor bone marrow transplantation for chronic myeloid leukemia. Impact of HLA class II matching. Chronic Leukemia Working Party of the European Group for Blood and Marrow Transplantation.
    Devergie A, Apperley JF, Labopin M, Madrigal A, Jacobsen N, Carreras E, Prentice HG, Jouet JP, Kolb HJ, Herstenstein B, Bacigalupo A, Evensen SA, Ljungman P, de Witte T, Reiffers J, Nagler A, Clark RE, Goldman JM, Gratwohl A.
    Bone Marrow Transplant; 1997 Jul 15; 20(1):11-9. PubMed ID: 9232250
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Effect of T cell subset dose on outcome of T cell-depleted bone marrow transplantation.
    Kawanishi Y, Passweg J, Drobyski WR, Rowlings P, Cook-Craig A, Casper J, Pietryga D, Garbrecht F, Camitta B, Horowitz M, Juckett M, Margolis D, Flomenberg N, Keever-Taylor CA.
    Bone Marrow Transplant; 1997 Jun 15; 19(11):1069-77. PubMed ID: 9193748
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 80.